BAIYUNSHAN PH - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

The Company does not make any statement and expressly disclaims any liability arising out of or in reliance upon the whole or any part of the contents of this announcement. assumes no responsibility for any losses caused by the content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to publish the information published by Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (the "Company") on the website of the Shanghai Stock Exchange (www.sse.com.cn)

The full Chinese text of the Company's announcement on the completion of the reelection of the Board of Directors and the appointment of senior management personnel is for reference only.

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

board of directors

Guangzhou, China, May 30, 2026

As of the date of this announcement, the Company’s Board of Directors includes (i) Executive Directors Mr. Chen Jiehui, Mr. Yuan Cheng, Mr. Cheng Hongjin, Mr. Tang Heping;

Sheng, Ms. Liu Miao and Mr. Liu Hong; (ii) Non-executive Director Mr. Huang Jiyuan: and (iii) Independent non-executive Directors Mr. Huang Longde and Sun Baoqing Madam, Mr. Wu Xiangneng and Mr. Yang Yinbao.

Securities code: 600332 Securities abbreviation: Baiyunshan Announcement number: 2026-033

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

Announcement on the completion of the re-election of the Board of Directors and the appointment of senior managers

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in this announcement, and that the contents of this announcement contain no false records, misleading statements or major omissions. bear legal responsibility for the authenticity, accuracy and completeness of the content.

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. ("the Company" or the "Company") will be

The 2025 annual shareholders’ meeting was held on March 29 to elect the directors of the company’s tenth board of directors.

The employee representative directors elected by the employee representative conference together constitute the company's tenth board of directors. On the same day,

The company held the first meeting of the 10th Board of Directors, which reviewed and approved the election of Chairman and Vice Chairman, and appointed

Appointment of members of special committees under the Board of Directors and relevant proposals for the appointment of senior management personnel. The details are as follows:

1. Composition of the tenth board of directors of the company

(1) Chairman: Mr. Chen Jiehui

Vice Chairman: Mr. Yuan Cheng

(2) Board members:

1. Executive directors: Mr. Chen Jiehui, Mr. Yuan Cheng, Mr. Cheng Hongjin, Mr. Tang Heping, Liu Ming

Madam, Mr. Liu Hong (Employee Representative Director)

2. Non-executive Director: Mr. Huang Jiyuan

3. Independent non-executive directors: Mr. Huang Longde, Ms. Sun Baoqing, Mr. Wu Xiangneng and Mr. Yang Yinbao

give birth to

(3) Composition of special committees of the board of directors:

1. Audit Committee: Mr. Huang Longde (Committee Chairman), Ms. Sun Baoqing, Mr. Wu Xiangneng

and Mr. Yang Yinbao

2. Strategic Development and Investment Committee: Mr. Chen Jiehui (Committee Chairman), Mr. Yuan Cheng, Liu

Mr. Hong, Mr. Wu Xiangneng and Mr. Yang Yinbao

3. Nomination and Remuneration Committee: Mr. Yang Yinbao (Committee Chairman), Mr. Cheng Hongjin, Liu Miao

Ms. Sun Baoqing and Mr. Wu Xiangneng.

4. Budget Committee: Mr. Wu Xiangneng (Committee Chairman), Mr. Tang Heping, Mr. Huang Jiyuan,

Mr. Huang Longde and Mr. Yang Yinbao.

The term of office of the members of the above-mentioned special committees shall be consistent with the term of the tenth session of the Board of Directors of the Company.

2. Appointment status of senior management personnel of the company

(1) General Manager: Mr. Yuan Cheng

(2) Deputy General Managers: Ms. Zheng Haoshan, Mr. Zheng Jianxiong

(3) Secretary of the Board of Directors: Ms. Huang Xuezhen

(4) Financial Director: Ms. Liu Fei

The term of office of the above-mentioned senior management personnel ("the above-mentioned personnel") shall be consistent with the term of the tenth session of the Board of Directors of the Company.

The Nomination and Remuneration Committee of the ninth session of the Company’s Board of Directors has reviewed the qualifications and conditions of the above-mentioned personnel.

After review, it was not found that the Company Law, Shanghai Stock Exchange Stock Listing Rules, or Shanghai Securities

Self-regulatory Guidelines for Listed Companies on the Exchange No. 1 - Standardized Operations" stipulates that you are not allowed to serve as a senior manager of the company

He has not been punished by the China Securities Regulatory Commission, stock exchanges and other relevant departments, and has no

Being investigated by judicial authorities for suspected crimes or being investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations, etc.

situation, he is not the person subject to execution for breach of trust, and his qualifications are in compliance with the Company Law and the Shanghai Stock Exchange Stock Exchange

Listing Rules" "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations" "Company

Articles of Association and other relevant provisions, their educational background, work experience, professional abilities and professional qualities can be qualified for the proposed tasks.

Position held.

As of now, except for Mr. Zheng Jianxiong, who holds 2,300 A shares of the company, the above-mentioned personnel have

None of the personnel holds shares in the company. Except for their disclosed employment status, the above personnel are not related to other directors and directors of the company.

There is no related relationship between senior managers, actual controllers and shareholders holding more than 5% of the company's shares.

Comply with the qualifications and independence requirements stipulated in relevant laws, regulations and normative documents.

Ms. Huang Xuezhen, secretary of the board of directors, has obtained the board secretary qualification certificate issued by the Shanghai Stock Exchange

He has more than 5 years of work experience required to perform his duties. The contact information of the secretary of the company's board of directors has not changed.

3. Changes and resignations in the company

After the company's general election is completed, Mr. Li Xiaojun and Mr. Li Hong will no longer serve as directors due to the expiration of their terms.

The company's executive directors; Mr. Chen Yajin and Mr. Huang Min no longer serve as the company's independent non-executive directors. company to

During their tenure, Mr. Li Xiaojun, Mr. Li Hong, Mr. Chen Yajin and Mr. Huang Min standardized the company's operations and

Thank you very much for your contribution to sustainable and healthy development!

For details of the resumes of the members of the tenth board of directors of the company, please see the company’s announcement on the Shanghai Stock Exchange on May 7, 2026.

"Announcement on the General Election of the Board of Directors" disclosed on the website (www.sse.com.cn) (Announcement No.:

2026-026) and the "Announcement on the Election of Employee Representative Directors" disclosed on May 15, 2026 (Announcement

No.: 2026-030), the resumes of senior managers are detailed in the attachment.

Announcement is hereby made.

Board of Directors of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

May 30, 2026

Attached: Resume

(1) Senior management personnel

1. General Manager

Mr. Yuan Cheng, 56 years old, holds a bachelor’s degree and a bachelor’s degree in science. He holds the title of senior pharmaceutical engineer.

High-level talent of the State-owned Assets Supervision and Administration Commission of the state and city, executive director of the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation

Deputy Director. Mr. Yuan started working in July 1992 and served as laboratory manager of Guangzhou No. 10 Pharmaceutical Factory.

Cadre, deputy section chief of the Technical and Quality Section, section chief of the Supply and Marketing Section, manager and deputy general manager of the business department of Guangzhou Huanye Pharmaceutical Co., Ltd.

Manager, Deputy General Manager and General Manager of Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. ("Baiyunshan Hanfang")

Manager, Party branch secretary and other positions. Mr. Yuan is currently the party committee secretary and chairman of Baiyunshan Hanfang. Mr. Yuan is here

Pharmaceutical enterprise production management, technical quality, marketing, drug research and development and enterprise management, etc.

Rich experience and profound industry accumulation.

2. Deputy General Manager

Ms. Zheng Haoshan, 50 years old, holds a master's degree in management and holds the title of senior economist. Ms. Zheng Haoshan once

He has successively served as deputy director of the enterprise management department, deputy director of the marketing department, and enterprise management technical director of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.

Deputy Director and Director of the Quality Department, Deputy Director and Director of the Enterprise Management Department of Guangzhou Pharmaceutical Group Co., Ltd. Ms. Zheng since 2019

He has been the deputy general manager of the Company since July 2018 and currently serves as a director of Guangzhou Pharmaceutical Co., Ltd. ("Guangzhou Pharmaceutical").

He is the Secretary and Chairman of the Party Branch of Guangzhou Baiyunshan Baidi Biopharmaceutical Co., Ltd. Ms. Zheng Haoshan is in the company

He has extensive experience in industry management, resource integration, and operational analysis.

Mr. Zheng Jianxiong, 56 years old, holds a master's degree in business administration, is a senior economist and is a pharmacist in charge. Zheng Xian

Born in July 1993 and started working, he has served as Director of Shanghai Office and Deputy Sales Director of Guangzhou Pharmaceutical Company.

Ren; Director of Overseas Sales Department, Director of Purchasing Department, Vice President of Guangzhou Pharmaceutical Co., Ltd.; Guangzhou Caizhilin Pharmaceutical Co., Ltd.

He holds the positions of deputy general manager of the company ("Caizhilin Pharmaceutical") and chairman of the Guangzhou Caizhilin Pharmaceutical chain store. Zheng Xian

Sheng has been a member of the party committee and deputy general manager of the company since August 2020. He is currently a director of Caizhilin Pharmaceutical and a director of Guangzhou

Director of Baiyunshan Medical Equipment Investment Co., Ltd., Director of Guangzhou Zhongcheng Medical Equipment Industry Development Co., Ltd.

Chairman of GPHL (Macau) International Development Industry Co., Ltd., GPHL International Pharmaceutical Industry Development (Zhuhai)

Hengqin) Co., Ltd. and Guangzhou Shennong Modern Agriculture Co., Ltd. Mr. Zheng is running the business

He has extensive experience in management and marketing.

3. Secretary of the Board of Directors

Ms. Huang Xuezhen, 52 years old, master’s degree, Master of Arts, financial economist (intermediate)

Professional title, non-party person, Member Representative of the Third Council of China Association of Public Companies, Guangzhou Li

Representative to the 15th Bay Area People’s Congress. Ms. Huang started working in July 1999 and joined the company in September 2003

The company, he has served as the company’s securities affairs representative, deputy director of the board secretariat, and director of the secretariat.

and other positions. Ms. Huang has been the Secretary of the Board of Directors of the Company since April 26, 2017, and is currently the CEO of the Company.

Secretary of the company, director of the Board Secretary Office and director of Golden Eagle Fund Management Co., Ltd.

4. Financial Director

Ms. Liu Fei, 49 years old, holds a master’s degree in accounting and holds the title of senior accountant. Ms. Liu participated in the

As he continued to work, he successively served as the manager of the financial department of Guangzhou Wanglaoji Health Industry Co., Ltd., and the manager of Guangzhou Pharmaceutical Co., Ltd.

Head of the Finance Department of the Co., Ltd., Deputy Director of the Finance Department of the Company, Vice President of Guangzhou Pharmaceutical Import and Export Co., Ltd.

General Manager, Deputy General Manager of Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. ("Tianxin Pharmaceutical"), Treasurer of the Company

He holds positions such as deputy director of financial affairs and currently serves as the financial director of the company, Guangzhou Caizhilin Pharmaceutical Co., Ltd. and Tianxin Pharmaceutical

Director, Guangzhou Baiyunshan Baidi Biopharmaceutical Co., Ltd., Guangzhou Chuangying Guangyao Baiyunshan Intellectual Property Co., Ltd.

Company, Guangzhou Baiyunshan Biological Products Co., Ltd., Guangzhou Baite Qiaoguang Medical Products Co., Ltd. and

Supervisor of Golden Eagle Fund Management Co., Ltd. Ms. Liu has extensive experience in financial management and budget management.

test.